Reveal the power of the 6-base genome



April 3, 2024

  • Share
  • In this episode, we speak with Tom Charlesworth, Director, Market Strategy and Corporate Development at biomodal and discuss the revolutionary impact of the 6-base genome on elucidating tumour biology through liquid biopsy through: Unveiling methylation states of enhancers in CRC cfDNA samples, offering compelling evidence of 5mC and 5hmC's precise tracking of cancer stage. Two-dimensional methylation data from 6-letter readouts, unveiling 5hmC variations distinctly associated with stage 1 cancer versus healthy states. A comprehensive overview of leveraging 6-base genome data to construct predictive models for gene expression, chromatin accessibility, and enhancer status with unparalleled accuracy. Join us as we navigate the frontiers of genomic innovation and its profound implications for understanding and combating disease.

    Analytical TechniquesCell ScienceGenomics

    Keep up to date with all your favourite videos and channels.

    Get personalised notifications on new releases and channel content by subscribing to the LabTube eNewsletter.